A director at Scout24 SE bought 2,910 shares at 85.500EUR and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
BUREAU VERITAS: Number of shares and voting rights as of November 30, 2025 REGULATED INFORMATION Courbevoie, France – December 15, 2025 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas DateNumber of shares (1)Number of voting rights30/11/2025453,916,256 Theoretical number of voting rights: 560,890,697 Number of exercisable voting rights: 550,627,131 (1) including the new shares issued in Euroclear as a result of the exercise of stock options since Ja...
BUREAU VERITAS : Nombre d'actions et de droits de vote au 30 novembre 2025 INFORMATION RÈGLEMENTÉE Courbevoie, France – 15 décembre 2025 Information relative au nombre d’actions et de droits de vote prévue par l’article 223-16 du règlement général de l’Autorité des marchés financiers Emetteur : Bureau Veritas Date de l’arrêté Nombre d’actions en circulation (1) Nombre total de droits de vote 30/11/2025 453 916 256 Nombre de droits de vote théoriques : 560 890 697 Nombre de droits de vote exerçables : 550 627 131 (1) y compris les ac...
Bureau Veritas - New appointments to the Board of Directors PRESS RELEASE Courbevoie – December 15th, 2025 New appointments to Bureau Veritas’ Board of Directors , a global leader in Testing, Inspection and Certification (TIC), announces that the Board of Directors, under the chairmanship of Mr. Laurent Mignon, has appointed Mr. Geoffroy Roux de Bézieux as Lead Independent Director, Chairman of the Nomination & Compensation Committee, and Vice-Chairman of the Company’s Board of Directors, replacing Mr. Pascal Lebard who no longer qualifies as independent after twelve years of directorshi...
Bureau Veritas - Nouvelles nominations au sein du Conseil d’administration COMMUNIQUE DE PRESSE Courbevoie – 15 décembre 2025 Nouvelles nominations au sein du Conseil d’administration de Bureau Veritas , un leader mondial des essais, de l’inspection et de la certification, annonce que le Conseil d’administration, sous la présidence de Monsieur Laurent Mignon, a nommé Monsieur Geoffroy Roux de Bézieux en qualité d’Administrateur Référent indépendant, de Président du Comité des nominations et des rémunérations et de Vice-Président du Conseil d’administration de la Société, en rempl...
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...
BUREAU VERITAS: Number of shares and voting rights as of November 30, 2025 REGULATED INFORMATION Courbevoie, France – December 8, 2025 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas DateNumber of shares (1)Number of voting rights30/11/2025453,916,256Theoretical number of voting rights: 560,890,697 Number of exercisable voting rights: 550,627,131 (1) including the new shares issued in Euroclear as a result of the exercise of stock options since Janua...
BUREAU VERITAS : Nombre d'actions et de droits de vote au 30 novembre 2025 INFORMATION RÈGLEMENTÉE Courbevoie, France – 8 décembre 2025 Information relative au nombre d’actions et de droits de vote prévue par l’article 223-16 du règlement général de l’Autorité des marchés financiers Emetteur : Bureau Veritas Date de l’arrêté Nombre d’actions en circulation (1) Nombre total de droits de vote 30/11/2025 453 916 256 Nombre de droits de vote théoriques : 560 890 697 Nombre de droits de vote exerçables : 550 627 131 (1) y compris les...
Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.